CT severity score: an imaging biomarker to estimate the severity of COVID-19 pneumonia in vaccinated and non-vaccinated population

• Published in: Egyptian Journal of Radiology and Nuclear Medicine Vol. 53; no. 1; pp. 1 - 8
• Main Authors: Gurumurthy, Balasubramanian, Das, Sudha Kiran, Shetty, Sachin, Veerabhadrappa, Rakesh Chowkalli, Kosinepalli, Sai Siddartha, Dharamaraju, Swathi Hassan
• Format: Journal Article
• Language: English
• Published: Berlin/Heidelberg Springer Berlin Heidelberg 12.04.2022; Springer; Springer Nature B.V; SpringerOpen
• Subjects: Age; Bacterial pneumonia; Cardiovascular disease; Chronic obstructive pulmonary disease; Coronaviruses; Covaxin; COVID-19; COVID-19 vaccines; Covishield; CT imaging; CT severity score; Diabetes; Dyspnea; Health aspects; Hemoptysis; Hypertension; Imaging; Immunization; Infections; Medical research; Medicine; Medicine & Public Health; Medicine, Experimental; Nuclear Medicine; Pandemics; Pneumonia; Radiology; Risk factors; Severe acute respiratory syndrome coronavirus 2; Statistical analysis; Vaccination; United Kingdom; India; COVID-19; CT severity score; Covishield; Covaxin

Background In India, two vaccines received emergent use authorization, namely Covishield (a brand of the Oxford—Astra Zeneca vaccine manufactured by the Serum institute of India) and Covaxin (developed by Bharat Biotech) against COVID-19 disease. Chest CT is an objective way to assess the extent of...